ADELPHANE-ESIDREX

This brand name is authorized in Estonia

Active ingredients

The drug ADELPHANE-ESIDREX contains a combination of these active pharmaceutical ingredients (APIs):

1 Reserpine UNII 8B1QWR724A - RESERPINE

Read about Reserpine

2 Dihydralazine UNII 1C2B1W91NK - DIHYDRALAZINE SULFATE

Dihydralazine is a member of phthalazines. Read about Dihydralazine

3 Hydrochlorothiazide UNII 0J48LPH2TH - HYDROCHLOROTHIAZIDE

Hydrochlorothiazide is a diuretic with antihypertensive properties. It acts by inhibiting the renal tubular re-absorption of sodium and chloride ions, which are excreted with an accompanying volume of water. Potassium excretion is also promoted. Read about Hydrochlorothiazide

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
C02LA51	Reserpine and diuretics, combinations with other drugs	C Cardiovascular system → C02 Antihypertensives → C02L Antihypertensives and diuretics in combination → C02LA Rauwolfia alkaloids and diuretics in combination
Discover more medicines within C02LA51

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: EE	Ravimiamet	Identifier(s): 1469415, 1629312